TD Asset Management »

Peregrine Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $830k 128k 6.50
2023-09-30 $1.1M 115k 9.44
2023-06-30 $1.5M 108k 13.97
2023-03-31 $2.0M 108k 18.76
2022-12-31 $1.4M 101k 13.77
2022-09-30 $845k 45k 18.78